Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
It is currently in Phase 3 clinical trials, and approval is not expected for at least another 1-2 years at the earliest
In the future, the focus should be on its reproductive safety, long-term efficacy, and integration with other therapies, ultimately achieving effective transformation from basic research to clinical practice
That does not establish a universal clinical outcome for every human patient
Tirzepatide has a half-life of approximately 5 days, meaning it takes about four to five weeks of consistent weekly dosing to reach steady-state concentrations in the body
US$ 28.07
US$ 28.90
US$ 21.38
US$ 20.65
US$ 28.24
US$ 27.90
US$ 23.35
